Company News: Page (1) of 1 - 07/13/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Mallinckrodt Phase 3 Terlipressin Trial Achieves its Enrollment Target Ahead of Schedule

-- Terlipressin CONFIRM Phase 3 Trial Enrolls 75th Patient of 300-Patient Target Enrollment; Marks Halfway Point toward Interim Analysis of Trial Data -- (July 13, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Management,Presentors,Business,Business Issues,Presentation,Channel/Distribution,Canada,USA,Medicine,Disease,Pregnancy,Surgery,Medication,Pregnancy,Science,Medical,Biology,Chemistry,Business,Other,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved